KUALA LUMPUR KEPONG BHD (KLK)

Kuala Lumpur Kepong Berhad (KLK) — More Than Just a Plantation Company

Most investors still think of KLK as a straightforward palm oil company. The reality is more compelling: KLK is undergoing a genuine strategic transformation — from a traditional plantation conglomerate into a diversified land-asset powerhouse combining mature plantations, oleochemical manufacturing, and now, high-technology industrial parks. This is not the same company it was a decade ago.

Founded in 1897 by British investors and now listed on the Main Market of Bursa Malaysia under stock code 2445, KLK commands a market capitalisation of approximately RM 23.6 billion. It ranks among the top-five plantation companies in Malaysia and holds a constituent position in the FBM KLCI index.

Three Core Business Segments

Key Statistics (April 2026)

The Transformation Story: From Plantation to TechPark

What sets KLK apart from its plantation peers is the KLK TechPark Tanjong Malim — a large-scale industrial park built on former KLK plantation land with a gross development value of RM 3.5 billion. The project gained significant momentum when BYD, the world's largest electric vehicle manufacturer, confirmed its facility within the park. This is not ordinary property development — it represents the conversion of century-old land holdings into high-value commercial use.

In Johor, KLK has established a joint venture with Mah Sing Group to develop a project within the JS-SEZ (Johor-Singapore Special Economic Zone) with GDV of RM 2.26 billion, alongside another JV with AME Elite in Ijok, Selangor. These moves signal that KLK is seriously deploying its historical land bank as a new growth engine.

The Challenge: Synthomer Remains a Headwind

KLK's manufacturing segment, specifically its 26.3% stake in Synthomer Plc (a specialty chemicals company listed in London), continues to weigh on reported earnings. In FY25, KLK absorbed a non-cash loss of RM 187.5 million from Synthomer plus RM 157.2 million in foreign exchange losses. The combined drag of RM 344.7 million suppressed what would otherwise have been substantially higher reported profits. Understanding this distortion is essential for accurately valuing KLK.

This is the single most important thing to understand this quarter: the reported numbers and the true core-business numbers tell two very different stories.

Reported: Net loss of RM1.34 billion for 3QFY26 (driven entirely by the RM1.6 billion Synthomer impairment).

Normalized (core, ex-impairment): 9-month PATAMI grew 43% YoY to ~RM1.12 billion — the core business is genuinely expanding.

*3QFY26 figures are derived from 9-month cumulative results minus 1H26 (not yet fully scraped into the i3investor database at the time of this update; cross-verified against The Star & BusinessToday coverage, 24-26 Aug 2026).

The good news: the Synthomer impairment is a non-cash item — it does not erode actual operating cash flow, so KLK's ability to pay dividends is fundamentally unaffected by this write-down.

• An interim dividend of 20 sen/share was declared alongside the 2QFY26 results (entitlement date 10 July 2026, paid 28 July 2026) — BEFORE the 3QFY26 impairment was announced.
• Consistent with KLK's historical pattern (Q1 & Q3 = no interim dividend; Q2 = interim; Q4 = final dividend), no new interim dividend is expected/declared alongside the 3QFY26 results — this is normal, not a sign of cash-flow stress.
• Current yield based on market price ~RM21.70: using the recent annual DPS pattern (20+40 = 60 sen per FY), estimated gross dividend yield is ~2.7-2.8%.